In this regard, FMT has been shown to improve disease pre-clinically in NASH rats, by restoring the insulin/p-Akt/p-eNOS signaling pathway, thereby improving IR and ED [11]. This evidence concerns the gene AKT1 and metabolic dysfunction-associated steatohepatitis.